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a b s t r a c t 
The Knowledge about the use of counterfeit medicines in Lebanon is still very limited. Thus, the objective of this 
study was to evaluate the degree of awareness of counterfeit medicines among the Lebanese population and the 
harm associated with their consumption. A cross-sectional study based on a questionnaire survey has been applied 
where a semi-structured survey questionnaire was distributed, between June 2017 and May 2018, among 750 
participants from 98 Lebanese areas to assess their awareness regarding counterfeit medicines. Seven hundred 
and four participants completed the questionnaire. 55.4% purchased medicines regularly. The main sources of 
medicines were pharmacies (52.6%), government clinics (16.3%) and private clinics (8.7%). The most common 
purchased medicines were lifesaving ones (80%). In the majority of cases (71.9%), participants could not identify 
the manufacturer country. Overall, 46.2% of the participants were aware of counterfeit medicines. 5.4% of the 
participants experienced self-reporting adverse effects, among which 89.5% of cases were reported to pharmacists 
or other authorities. Despite the risk, 4.7% of participants were willing to buy a potential counterfeit medicine. 
In fact, 56. 4% of the participants associated low harm level with the use of counterfeit medicines. Despite their 
awareness of counterfeit drugs-associated risks, the majority of participants tend to buy them again. Informative 
public health campaign and health professionals training, to prevent counterfeit medicines-associated harms, 








































Counterfeiting is the act of deliberately imitating an original prod-
ct with a purpose to steal, to destroy, or to replace the original product
or use in illegal transactions as well as to deceive and to dupe the cus-
omer into believing that the fake merchandise are of equal or greater
alue than the real one. Counterfeit medicines represent a public health
hreat and are often associated with long-term consequences including
ancer and heart disease ( Jung, 2007 ). Medicine counterfeiting has been
dentified by the World Health Organisation (WHO) as an international
roblem back in 1985. Accordingly, the WHO and the Food and Drugs
dministration (FDA) identifies a counterfeit medicine by presenting at
east one of the following criteria: (1) contaminated sample; (2) con-
aining the wrong active pharmaceutical ingredient (API); (3) formed
ithout an API; (4) have the right API but with wrong quantity; (5)
nd/or have the wrong excipients ( Perera et al., 1996 ; WHO, 2018 ).
edicine counterfeiting is not limited to defects in chemical constituents∗ Corresponding author. 
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ging or a forged documentation or labeling of the box and the leaflet.
lthough medicine counterfeiting is more common in countries with
oor regulatory or enforcement regimes, certain developed countries
re even witnessing the spread of that phenomenon and that might be
ue to a weakness in their enforcement aspect. In January 2016, the
HO agreed to adopt the term “substandard and falsified (SF) ” medical
roducts for those currently known as “substandard/spurious/falsely-
abeled/falsified/counterfeit (SSFFC) ” medical products. In fact, the
ubstandard products, (designated “out of specification ”) are authorised
edical products that fail to meet either the quality standards or speci-
cation or both. However, the counterfeited medication is neither reg-
lated nor quality controlled. 
Medicine counterfeiting is not exclusive to a certain pharmacolog-
cal class. It spans both lifestyle and lifesaving medicines such as: an-
ibiotic ( Delepierre et al., 2012 ), antidiabetics ( Yao et al., 2007 ), anxi-
lytics ( CC., 2019 ), cardiovascular ( Antignac et al., 2017 ), sexual stimu-
ants ( Jackson et al., 2010 ) and weight loss products ( Malet-Martino and
artino, 2015 ). Lifestyle drugs are more prone to falsification. Lifestyle
rugs are considered to be the drugs that are used to treat none threaten-
ng and none painful cases such as baldness, wrinkles, impotence or acne21 
he Study of Emerging Drugs. This is an open access article under the CC 




























































































































a  hat are perceived as a minor medical problem relative to others. Even
hough some lifestyle medications can help in improving our health but
hey are not considered curative or lifesaving as a patient’s life won’t be
t risk if they did not use or consume it. 
In 2017, the WHO estimated that 10.5 % of medicines around the
orld were substandard or falsified ( WHO, 2017 ). A systematic review
n 2018 shed light that the prevalence of substandard and falsified
edicines (based on published surveys between 2007 and 2016) was
3.6% in low-and middle- income countries with an overall regional
revalence of 18.7% in Africa and 13.7% in Asia. In this perspective, the
stimated economic impact extended widely from $10 billion to $200
illion ( Ozawa et al., 2018 ; WHO, 2017 ). 
In 1982, and during the civil war, 57 different medicines were re-
orted, in Lebanon, as counterfeit ( Sholy et al., 2018 ). Subsequently,
overnmental controls became obligatory where each medicine must
ow be registered and approved by the Ministry of Public Health
MoPH) before distribution to the market ( MOPH ). In 2004, 3D holo-
rams to test imported drugs’ authenticity were put in place and have
een used since ( MOPH, 2012 ). The 3D hologram is a security feature
agged on the product. It is mainly used to prevent counterfeiting and
t is constituted by a visual authentication. This latter is extremely dif-
cult to be copied since it is fabricated from a type of display using
ight diffraction generating three-dimensional image pattern. Despite its
mportance and immense impact on public health, studies evaluating
harmacists and public knowledge about counterfeit medicines are lim-
ted ( Shahverdi et al., 2012 , Ivanitskaya et al., 2010 , Assi et al., 2016 ,
ybecker, 2007 , Pál et al., 2015 , Desai et al., 2015 , Tipke et al., 2008 ,
engaloundeth et al., 2009 ). 
Medicines in Lebanon are only found in pharmacies and dispensed
y registered pharmacists. . Counterfeiting medicines encountered in
ebanon were reported in several studies. . In 2010, it was reported that
ine pharmacies and four warehouses were closed for possessing coun-
erfeit Plavix (clopidogrel) where the boxes held the official hologram
hile their security label was counterfeit ( Sholy and Saliba, 2018 ). In a
tudy done in 2018 showed the statistical extent of counterfeited drugs
n some Lebanese regions. The study showed that 4% of counterfeiting
s found in Mount Lebanon, 12% in the South and Bekaa ( Sholy and
aliba, 2018 ). The previous study mentioned, recruited more numbers
f participants for about 849 whereas the present study included 704
andidates. Unfortunately, there is a lack of studies related to medicinal
ounterfeiting in Lebanon. Some surveys have been made to assess the
wareness of Lebanese pharmacists and views towards falsified medi-
ations. According to a survey made in 2011, the results showed that
ost of the interviewed correlates counterfeit medications to being a
ad quality medication or one of an unknown source. The interviewed
ere aware of some pharmacists dispensing counterfeits and considered
hem unprofessional and unethical ( Sholy et al., 2018 ). They also be-
ieve in strengthening the legislations against counterfeiting. Moreover,
t was noticed that pharmacists in the Bekaa region were least likely to
eport knowing about pharmacists dispensing counterfeits and this is ei-
her due to their lack of knowledge or due to a link to organised crimes
 Sholy et al., 2018 ). The main contributing factors in increasing coun-
erfeits in Lebanon are the lack of awareness of the pharmacists and the
onsumers for a counterfeit reporting system. The increase in the num-
er of graduating pharmacists in contrast to a decrease in the minimum
ages. The corruption that increases the prevalence of falsified medica-
ions in the trade causing a mistrust of the healthcare system. Last but
ot least, the shortage of medications that leads to an increase in the de-
and of cheaper drugs that are most likely to be falsified ( Sholy et al.,
018 ). 
This work is based on a questionnaire survey designed to evalu-
te the knowledge of Lebanese people and their perceptions concerning
revalence and harm associated with counterfeit medicines. In addition,
he questionnaire explored the prevalence of counterfeits per the ma-
or Lebanese districts specifically Bekaa, Mount of Lebanon, Nabatyeh,
orth and South of Lebanon. v  
2 ethods 
tudy design 
To further asses the Lebanese public health knowledge and aware-
ess on the prevalence of counterfeited medication and its harmful side
ffect, a cross sectional study has been employed using a questionnaire
urvey. The survey design was based on a study previously conducted
n the United Kingdom concerning purchasing medicinal and lifestyle
roducts ( Assi et al., 2016 ). It has been modified and adapted according
o the country’s aspects and the targets of the study. All procedures per-
ormed in studies involving human participants were in accordance with
he 1964 Helsinki declaration and its later amendments. Prior to com-
letion of the questionnaire, the participants were supplied with a study
nformation leaflet and a consent form. The study information leaflet
xplained the aim and the objectives of the research and the outcomes
ought behind conducting it. Participants were also made aware of their
ight to withdraw from completing the questionnaire at any stage. No
ersonal or identifiable data was collected. The questionnaire was pi-
oted by two persons respecting the national guidelines for researchers
n Lebanon in terms of transparency, objectivity, precision, confidential-
ty, strict adherence to the “International Declaration of Human Rights ”.
uestionnaire development 
As reference, a previous questionnaire used by Bournemouth Uni-
ersity was used as a guideline to construct our form ( Assi et al., 2016 ).
he questionnaire was composed of 37 questions and divided into five
arts ( Table 1 ): (I) demography of participants, (II) extent of buying
edicines, (III) types of purchased medicines, (IV) awareness of coun-
erfeit medicines and (V) awareness of adverse events associated with-
ounterfeit medicines. Respectively, the first part of the survey covered
he demographic information specifically gender, age, nationality, spo-
en language(s), education level and job. The second part explored the
spects applied for buying medicines in terms of the regular purchase
f medicines, the sources of information about medicines awareness,
he medicines purchase places, the country of origin and the authentic-
ty identification. The third part of the survey assessed the most used
nd bought medicines in Lebanon. The fourth part of the survey is re-
ated to the awareness of the consumer on (1) counterfeit medicines, (2)
he manner in which a medicine’s originality is checked. Furthermore,
he latter section included whether the participants have ever encoun-
ered any counterfeit medication and if the case was reported to the
pecialised authority. The final part inspected the awareness of the par-
icipants on the adverse consequences resulted by counterfeit medicine
sage. In fact, we have asked the participants whether they have expe-
ienced any adverse events as a result of using a potential counterfeit
edicines and describing the effects. Participants were also questioned
f they accepted to take the risk of buying counterfeit medicines. In the
nd of the questionnaire, an evaluation on a scale of 1 to 10, was pro-
ided to establish the extent of the participants’ belief to the harm asso-
iated with counterfeit medicines. 
ata collection 
Prior to distribution, the questionnaire was piloted for 30 medicines’
sers in order to insure face and content validity. The opinions of the
articipants were considered and the necessary changes, in terms of the
tructure and the content of the questions, were adequately altered in
he questionnaire. 
The questionnaire was disseminated over approximately one year
etween June 2017 and May 2018. The survey was mainly performed
n pharmacies where 750 copies of the questionnaire were prepared and
n copy was shown for all buyers who accepted to take part in the sur-
ey. The participants reflected the demography of the people visiting
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Table 1 
The survey design. 
Part Aims 
Demography Sociodemographic factorsEconomic factors 
Extent of buying medicines Frequency of buying medicinesSources of informationSources of bought productsCountry of medicines manufacturer 
Types of purchased medicines Medicinal productsHerbal, supplements and cosmetics products 
Awareness of counterfeit medicines Knowledge on counterfeit medicinesSources of knowledgeCriteria to check medicines’ authenticityEncounter counterfeit 
medicines 
Awareness of adverse effects of counterfeit medicines Opinion about the risk to buy unlicensed medicinesExperience with adverse effects associated with using a counterfeit 









































































a  he pharmacy. In addition, the survey included participants from differ-
nt Lebanese districts specifically Bekaa, Mount of Lebanon, Nabatyeh,
orth and South of Lebanon. 704 individuals took part in the survey.
ubsequently, the data obtained was meticulously scrutinised by two au-
hors (M.N. and S.A.) and the scripts were examined for missing data or
mbiguous information. Finally, 704 questionnaire data were included.
rior to completion of the questionnaire, the participants were supplied
ith a study information leaflet and a consent form. The study informa-
ion leaflet explained the aim and the objectives of the study and the
utcomes sought behind conducting it. The participants were also made
ware of their right to withdraw from completing the questionnaire at
ny stage. No personal or identifiable data was collected. 
Thus, the data collection process was conducted on 704 participants
etween June 2017 and May 2018 covering 98 cities and villages within
ebanon. Eligible participants were residing in Lebanon, aged above 18
ears old and understood Arabic and/or English. The questionnaire was
iloted by two persons respecting the national guidelines for researchers
n Lebanon in terms of transparency, objectivity, precision, confidential-
ty, strict adherence to the “International Declaration of Human Rights ”
 Hamze et al., 2016 ). The questionnaire was distributed anonymously
nd the selection of participants was done randomly with no personal
dentifiable information. Additionally, the survey was written in English
nd a translation for the questionnaire and the participants’ answers
ere accomplished when participants can only speak Arabic or French.
he survey was executed with a face-to-face contact where each one
asted for 15-25 minutes with voluntary participation. The samples were
hosen to be a representation of the entries’ country population based
n the gender, the education and the geographical differences. However,
ore focus was directed into Beirut city due to the high population den-
ity. 
tatistical analysis 
Data were entered manually into SPSS version 24. Variables were
hen coded and numbered prior to data analysis. Data were summarised
sing frequency and percentages. In this study, we were interested in sta-
istical information (frequency (%)) regarding the demographic charac-
eristics of the participants, the participants’ extent on buying medicines,
he main purchased medicinal classes, the knowledge of participants
egarding counterfeit medicines and finally the participants’ behavior
owards counterfeit medicines. 
esults 
Out of 750 invitations, a total of 704 participants completed the sur-
ey and were all included in the study (93.87%). The participants were
pread over five main Lebanese governorates being: Bekaa, Mount of
ebanon, Nabatyeh, North and South of Lebanon ( Fig. 1 ). 
emographic characteristics of the participants 
The response rate was similar among males and females correspond-
ng to 53.1% and 46.2%, respectively ( Table 2 ). Participants’ age range
as equally distributed among the different age groups with a mean age
f 33.5 ± 7. The majority of the participants had a Lebanese nationality3 84.8%). The educational level of the contributors was between school
evel (46.6%) or University Bachelor level (36.9%) and they spoke more
han one language (70.5%). When asked about their occupation, more
han half of the participants had jobs in retail (such as shops and stores).
articipants and medicines 
Only 14.5% of the participants reported purchasing medicines regu-
arly, whereas, 17.8% and 21.2% of the participants reported purchasing
edicines occasionally or rarely respectively ( Table 3 ). The main medi-
ation sources were pharmacies (52.6%) followed by governmental clin-
cs (16.3%). Other sources including private clinics, hospitals, the Inter-
et, gyms and relatives from other countries were below 10% each. Only
4.4% of the participants could identify the manufacturing source of the
edicine purchased. Once identified, manufacturing sources included
urope (25.7%), USA and Canada (9.38%) and the Middle East (10.4%).
ore than half of the participants were not aware of specific markers to
heck the medicines’ authenticity. Participants often followed doctors’
ecommendation for choosing the specific medicine brand and referred
o doctors when seeking information about medicines. 
ain medicines classes purchased by participants 
Participants reported the purchase of both lifesaving and lifestyle
edicines equally (around 80%). The most purchased drugs were anti-
sthmatic and cardiovascular medicines that represented 22.3% and
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Table 2 
Demographic characteristics of the participants. 
Characteristic Frequency (%) 
Gender 
Male 374 (53.1) 
FemalePrefer not to say 325 (46.2)5(0.7) 
Age (years) 
18-25 130 (18.5) 
26-33 196 (27.8) 
34-41 181 (25.7) 
> 42 194 (27.6) 
NR 3 (0.4) 
Nationality 
Lebanese 594 (84.4) 
Syrian 45 (6.39) 
Iraqi 18 (2.56) 
Egyptian 12 (1.7) 
Indian 10 (1.42) 
Other nationalities 25 (3.55) 
Language(s) spoken 
Arabic only 146 (20.7) 
Arabic and English 188 (26.7) 
Arabic and French 114 (16.2) 
Arabic, English and French 194 (27.6) 
Other languages (not specified) 62 (8.8) 
Educational level 
High school/college 328 (46.6) 
Bachelor 260 (36.9) 
Masters or equivalent 95 (13.5) 
PhD 6 (0.9) 
NR 15 (2.10) 
Occupation 
Retail 57 (8.46) 
House wife 41 (6.08) 
Teacher 37 (5.49) 
Managerial 33 (4.9) 
Hospitality 26 (3.86) 
Taxi or bus driver 25 (3.71) 
Bakery 21 (3.12) 
Governmental organisation 21 (3.12) 
Other nationalities were reported below 1% 
each and included African, Ethiopian, Indonesian, 



























Participants and medicines. 
Participants extent of buying medicines Frequency (%) 
Frequency of purchase of medicines 
Regularly 102 (14.5) 
Occassionally 125 (17.8) 
Rarely 149 (21.2) 
NR 328 (46.6) 
Medicines purchase sources 
Pharmacies 370 (52.6) 
Governmental clinics 115 (16.3) 
Private clinics 61 (8.7) 
Hospitals 62 (8.8) 
Others ∗ 9 (1.28) 
NR 87 (12.4) 
Information availability regarding the manufacturing source 
Yes 172 (24.4) 
No 506 (71.9) 
NR 26 (3.7) 
Manufacturing sources of medicines 
Europe 181 (25.7) 
USA and Canada 66 (9.38) 
Middle East 73 (10.4) 
South America 2 (0.28) 
Asia 2 (0.28) 
Australia 2 (0.28) 
Russia 2 (0.28) 
NR 376 (53.4) 
Sources of information about medicines 
Doctors 413 (58.7) 
TV and magazines 153 (21.7) 
Events 133 (18.9) 
Others ∗ b 5 (0.71) 
Awareness of specific marker indicating medicine authenticity 
Yes 288 (40.9) 
No 385 (54.7) 
NR 31 (4.4) 
Seeking doctor’s advice for choosing the medicine brand 
Yes 462 (65.6) 
No 224 (31.8) 
NR 18 (2.57) 
∗ Others include internet, Overseas and Gym ∗ Others b include family and 
friends, brochures charities, gym and NGOs 
Table 4 
Main medicine classes purchased by participants. 
Medicine class Frequency (%) 
Antiasthmatic 157 (22.3) 
Cardiovascular 148 (21) 
Weight loss products 111 (15.8) 
Dietary supplements 99 (14.1) 
Antidiabetic 79 (11.2) 
Sleep aids 93 (13.2) 













S  1%, respectively ( Table 4 ). This was followed by weight loss products
15.8%), dietary supplements (14.1%) and sleep aids (13.2%) Moreover,
ntidiabetic and antidepressant drugs accounted for 11.2% and 9.38%
espectively. Other medicines included skin products, hair care prod-
cts, image enhancers and sexual stimulants, were purchased by less
han 1% of participants. 
nowledge of participants regarding counterfeit medicines 
Participants were split almost in equal proportion when asked about
wareness regarding counterfeit medicines ( Table 5 ). In this respect,
6.2% of participants were aware of counterfeit medicines, 46.4% were
ot aware whereas 7.4% did not answer. However, only 5.7% of par-
icipants encountered a counterfeit medicine and only 3.8% reported
t to the authorities. Most of the participants (92.9%) did not identify
ny health triggers that indicated the use of a counterfeit medication
hereas only 5% of participants indicated that the presence of an ad-
erse effect had been an indication of the use of counterfeit medicine.
he self-reported encountered adverse effects included cardiovascular
onsequences, fever and allergy. Experience of adverse effects associated
ith counterfeit medicines’ use 
Only 38 participants (5.4%) experienced adverse effects and associ-
ted it with the use of a counterfeit medicine ( Table 6 ). Once reported,
he aforementioned effects included allergy, fever and vomiting. 34 par-
icipants (4.83%) reported the adverse effects to the authorities or phar-
acists. In addition, participants stated taking antibiotics or antiallergic
gents to counteract the aforementioned adverse effects. When asked4 bout the harm resulting from counterfeit, 53.02% of participants be-
ieved that counterfeit medicine has severe and harmful consequences.
espite awareness of harm associated with counterfeit medicines, 4.69%
f participants believed that it was acceptable to buy a falsified drug in
ases of medicine shortage or of cheaper prices. 
iscussion 
The current survey is the first study to provide comprehensive ex-
mination and analysis of public knowledge and perspectives in rela-
ion to the prevalence and harm associated with counterfeit medicines
mong the Lebanese public. In the preceding years, only few published
tudies have examined pharmacists’ awareness and observations to-
ards counterfeit medicines ( Sholy et al., 2018 , Sholy and Saliba, 2018 ,
holy et al., 2018 ) but without looking into the perspectives and expe-
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Table 5 
Knowledge of participants regarding counterfeit medicines. 
Characteristic Frequency (%) 
Awareness of a counterfeit medicine 
Yes 325 (46.2) 
No 327 (46.4) 
NR 52 (7.4) 
Encounter of a counterfeit medicine 
Yes 40 (5.7) 
No 654 (92.9) 
Reporting of an encountered counterfeit medicine to authorities 
Yes 27 (3.8) 
No 29 (4.1) 
NR 648 (92.1) 
Method of checking medicine authenticity 
Asking a doctor 246 (34.9) 
Asking a pharmacist 129 (18.3) 
Checking medicine tag 63 (8.9) 
Checking medicine barcode 56 (8) 
NR 210 (29.8) 
Indications that triggered the presence of a counterfeit medicine 
Encountering an adverse effect 35 (5) 
Appearance of the product 9 (1.3) 
Different package 3 (0.4) 
Different label 3 (0.4) 
NR 654 (92.9) 
Adverse effects attributed to counterfeit medicines 
Cardiovascular problems 70 (9.9) 
Fever 45 (6.4) 
Allergy 44 (6.3) 
Brain damage 41 (5.8) 
Vomiting 32 (4.5) 
Liver damage 20 (2.8) 
Death 16 (2.3) 
Coma 11 (1.6) 
Others 32 (4.54) 


































Participants behaviour towards counterfeit medicines. 
Characteristic Frequency (%) 
Experience of adverse effect due to a potential counterfeit medicine 
Yes 38 (5.4) 
No 660 (93.8) 
NR 6 (0.85) 
Characteristic of adverse effect attributed to a counterfeit medicine 
Allergy 14 (1.99) 
Fever 9 (1.28) 
Vomiting 9 (1.28) 
Different from effects on label claim 22 (3.13) 
Adverse effects reported to pharmacist or authority 
Yes 34 (4.83) 
No 657 (93.3) 
Medicines often taken to counterfeit adverse effects associated with 
counterfeit medicines 
Antibiotics 14 (1.99) 
Antiallergic 8 (1.14) 
Other 10 (1.42) 
Degree of harm attributed to counterfeit medicines 
1 24 (3.41) 
2 47 (6.68) 
3 80 (11.4) 
4 82 (11.7) 
5 98 (13.92) 
6 65 (9.23) 
7 116 (16.5) 
8 128 (18.2) 
9 58 (8.1) 
10 7 (0.99) 
Acceptability of buying a counterfeit medicine 
Yes 33 (4.69) 
No 667 (94.7) 
NR 4 (0.57) 
Reason for acceptability of buying a counterfeit medicine 
Lower price 21 (63.6) 
Medicine shortage 6 (18.2) 
Trying something new 2 (6.06) 
Hatred for medicines 1 (3.03) 
Good efficacy 1 (3.03) 




























c  ience of the patients.The size (704 participants), distribution (98 cities
ver the country)), range of age groups (18-42 + ) and quasi equality
etween males and females among the surveyed sample are sugges-
ive that this survey is a strong reflection/representation of the views
f the general public in Lebanon. In this survey, respondents’ level of
ducation was significantly higher than the average literacy level in the
ountry. This higher education level might be linked to increased ac-
ess to information and professionals (e.g. doctors and pharmacists);
n turn raising awareness and cautiousness in the accredited sources
 W Ł odarczak et al., 2017 ). Contrastingly, an insignificant percentage
f participants were reliant upon television and magazines for knowl-
dge. Effective communication between patients, healthcare providers
nd medicines suppliers was identified as significantly impacting patient
reatment, and was associated with a lowered risk of purchasing coun-
erfeit medicines ( Blackstone et al., 2014 ). However, as the majority of
he participants did not demonstrate any commitment or preference to
isit the same pharmacy/pharmacist for services, it was suggested that,
otentially, a lower degree of patients’ counselling and education would
ake place, due to a lack of patient-professional relationship and conti-
uity ( O’Neil and Poirer, 1998 ). 
Additionally, it is noteworthy that the main source of medicines pur-
hased by regular patients ( > 50%) were pharmacies, hospitals, govern-
ent and private clinics (86.4%). Despite this, participants’ awareness
f counterfeit medicines was identified to be 46.2%. This is indicative of
 negative perception/experience to professional healthcare providers
ho deal with eliminating counterfeited medications from the legiti-
ate supply chain ( Sholy et al., 2018 , Alfadl et al., 2014 ). As opposed
o providing safe and effective medicines, which would foster trust, the
upply of counterfeit medicines has cast doubt and caused damage to
he professionalism and credibility of healthcare professionals working
n the pharmacy practice or healthcare sector ( Shahverdi et al., 2012 ,
holy et al., 2018 , Abu Taleb and Al Madadha, 2013 ). The previous ap-5 roach adopted by some healthcare professionals, may negatively im-
act the reputation of pharmacists simply by association through title
nd profession ( DiPiro, 2011 ). However, in the presence of a close pro-
essional relationship between patients and pharmacist, a reduction in
he chances of exposure to counterfeit medicines may be achieved. As
harmacists are the last point of patient contact, they are in an ideal
osition to educate patients on identifying counterfeit medicines, and
ncreasing awareness of the potential risks associated with their use or
onsumption ( Barrett and Al-Mousawi, 2018 ). Despite the high level
f education, it was surprising to note that approximately 75% of par-
icipants did not identify or pay attention to the country of origin of
edicines. This could be related to the lack of reading, culture and/or
he fast pace of life ( Sholy, 2015 ). 
Regarding the medicines manufacturing sources, many were found
o originate from France, the UK and the USA. It was also reported that
irca 30-40% of all medicines supplied to some parts of the Middle East
re counterfeit ( El-Jardali et al., 2015 ). Thus, it is crucial to identify
ounterfeit medicines at entry ports, by robust drug registration sys-
em via government agencies. Drugs’ entry can be controlled by trained
harmacists who can recognize falsified or non-WHO certified medicines
 Hamilton et al., 2016 , El-Jardali et al., 2016 ). Approximately 3.6% of
he medicines were fabricated in Lebanon, indicating a recognizable im-
rovement of the national drugs manufacturing, and was conveyed in a
eport about the analysis of Lebanon’s pharmaceutical market in 2014
 Soueid et al., 2014 ). Our data demonstrated that majority of partici-
ants purchased lifesaving medicines as opposed to lifestyle medicine. 
For lifesaving medicines, anti-asthma products were mainly pur-
hased with 22.3%. This proportion may be explained by the increase















































































































f atmospheric pollution and the recent increase in household waste
n Lebanon ( Abdallah et al., 2018 , Tiotiu et al., 2020 ). Cardiovascu-
ar diseases accounted for the highest percentage (21.02%) of adverse
ffects; cardiovascular diseases are mainly attributed to obesity, smok-
ng and blood pressure complications ( Deek, 2016 ). A further identified
actor was high stress levels associated with the socio-economic status
f Lebanese people. Lifestyle products (e.g. skin and physical appear-
nce products) were the most purchased items, constituting around 80%
f the survey participants’ purchases, which could be explained by the
ell-known interest of Lebanese people in the cosmetics sector. 
A minor percentage of counterfeit cases were reported to the au-
horities. Merely 4.83% of adverse effects cases caused by counterfeit
edicines were reported to pharmacists and authorities, where 46.2%
f participants were aware of counterfeit medicines. Consequently, it is
f great importance to propose the subject of how and why suspected
ounterfeit medicines need to be reported. The lack of awareness and
nderstanding of counterfeit medicine related risks and the absence of
ounterfeit medicine reporting systems in Lebanon was also addressed
y Sholy, Gard ( Sholy et al., 2018 ). A strategic plan reporting counter-
eit medicines to a trustworthy pharmacist who is accessible and easy to
ommunicate with ( Sholy et al., 2018 , Barrett and Al-Mousawi, 2018 ,
riddle, 2013 ). 
Another major discussion point of the present research is that de-
pite high level of education, participants were willing to buy counterfeit
edicines (less than 5%) due to their lower price and stated medicine
hortages as a driving factor underlying this behaviuor. Sholy and Saliba
 Sholy and Saliba, 2018 ) previously reported that participants’ positive
erception towards counterfeit medicines increased due to the unafford-
bility and inaccessibility of original medicines. Participants also held
he belief that original medicines are superior to counterfeit medicines
 Celso et al., 2007 , Penz and Stöttinger, 2008 , Commuri, 2009 ). How-
ver, the attractive low prices may compensate for the lower efficacy
nd quality when people have a limited budget ( Sholy et al., 2018 ,
ng et al., 2001 ). Reduced prices of counterfeit medicines can be an at-
ractive alternative to those with low socio-economic status, particularly
hen the risk is very low or unknown ( Sholy et al., 2018 , Alfadl et al.,
014 ). In developing countries, the public is less concerned and con-
ribute greatly towards counterfeit medicines ( Alfadl et al., 2012 ). 
This study demonstrated that a continuous educational campaign
hould be provided by the Ministry of Public Health in order to empha-
ise the risk and consequences associated with counterfeit medicines, as
ell as highlighting the role of the healthcare sector to provide aware-
ess and prevent the use of counterfeit medicines. Thus, greater aware-
ess will reduce the chances of counterfeit medicines use. 
imitations 
Even though this study covered many regions in Lebanon from North
o South, more participants from additive regions are needed. Only five
ain governorates were covered due to time restriction. Moreover, some
articipants were poorly educated towards the use of medication, and
ould not understand the efficacy of this survey nor comprehend the
mportance of acquiring their responses. Thus, more participants were
nterviewed but not all taken into consideration in this survey. Likewise,
e need to bring the attention that there was no way to authenticate
ausality, the adverse reactions were self-reported by the users 
ecommendations 
This study was mainly done to reflect peoples’ knowledge for coun-
erfeit medications and subsequently grow their awareness through dif-
erent steps: 
- A novel policy should be implemented in all pharmacies and drug
stores to organize the patient-pharmacist relationship according to
professional standards. 6 - A drug registration system controlled by pharmacist is of main im-
portance to control medications import and limit the reception of
counterfeit medications: pharmacists should be trained and selected
by the government. 
- Last but not least, specialists and associations should organize cam-
paign for the public to raise people’s awareness over counterfeit med-
ications and prompt them to report any kind of adverse effect due
to counterfeit medications. 
onclusions 
Our study is the first to examine the knowledge and perspectives
f the Lebanese public towards the prevalence and harm associated
ith counterfeit medicines. Although the use of medicine is widespread
cross the country, especially for lifesaving drugs, the majority of the
ample relied on their doctors and pharmacists to check the original-
ty of such products as they were unable to do so and considered this
n issue of concern. Overall, the perception of risk was minimal, de-
pite some reported side-effects, and the scarcity of reported problems
o authorities. Not only further studies evaluating both the pharmacists
nd the public knowledge and perception are needed, but also informed
ublic health campaign and training for health professionals should be
mplemented in the country to prevent the harms associated with the
nwanted use of counterfeited products, which are becoming increas-
ngly available in a globalized society. 
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7 ppendix: The Questionnaire 
ntroduction 
Therefore, the aim of this questionnaire is to investigate the sources
nd extent of purchase of medicines over the wholesale supply chain,
he main medicine classes purchased and the public awareness of coun-
erfeit medicines as well as potential harm resulting associated with the
se of counterfeit medicines. 
Your participation is entirely voluntary. There is no right or wrong
nswer and I am interested in your own personal experiences and point







































































Y  f views. The identities of all participants will remain strictly confiden-
ial and it will not be possible to identify any individual. The overall aim
f the study is to make recommendations to reduce the risks resulting
rom the use of lifestyle products. This questionnaire should take around
5 minutes. 
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